ArticleOne health outlook2025
Molecular characterization of multidrug-resistant Escherichia coli in the Greater Accra Region, Ghana: a 'One Health' approach.
Article in One health outlook, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Prevalence of extended-spectrum β-lactamase and carbapenemase-producing Escherichia coli from patients, cattle, and environmental sources in northwest Amhara, Ethiopia: a one health approach.BMC microbiology · 2026Article
- Tetracyclines in the Modern Era: Global Consumption, Antimicrobial Resistance, Environmental Occurrence, and Degradation Techniques.Antibiotics (Basel, Switzerland) · 2025Review
- Prevalence of Antimicrobial and Colistin Resistance in Enterobacterales in Healthy Pigs in Ghana Before and After Farmer Education.Tropical medicine and infectious disease · 2025Article
- Enterobacterales and Antimicrobial Resistance in Feed, Water, and Slurry in Pig Production Farms in the Greater Accra Region of Ghana, 2024.Tropical medicine and infectious disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background"One Health," a concept that highlights the need to bring on board multiple players and actors together to address major health problems, has been proposed to be effective in data gathering to mitigate the menace of antimicrobial drug resistance (AMR). Genomic data on extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) across humans, animals, and the environment are limited in low- and middle-income countries (LMICs), including Ghana.
objectiveThis study determined the prevalence and patterns of AMR in E. coli from diverse sources, and characterized AMR genes, sequence types (STs), and plasmid replicon types in ESBL-EC. METHODOLOGY: In a cross-sectional study, we randomly collected 1500 specimens from healthy humans, cattle, pigs, lettuce, spring onions, pork, beef, and soil samples, between January 2022 - April 2023. E. coli was isolated by routine culture and confirmed by MALDI-TOF MS. E. coli isolates were screened for their susceptibility against 13 antimicrobial agents and ESBL-production. ESBL-EC isolates were whole-genome sequenced (WGS), and in silico analysis was used to determine AMR genes, sequence types (STs), and plasmid replicon types.
resultOf the 1500 specimens from diverse sources cultured, 140 (9.3%) were positive for E. coli. No E. coli was isolated from lettuce, spring onions, and pork. Fifty (35.7%) E. coli isolates were resistant to three or more of the antimicrobials tested, and 30 (21.4%) were ESBL-EC. The proportion of ESBL-EC identified in healthy humans were 14 (20%), cattle 9 (22.5%), pigs 3 (15%), beef 1 (50%) and soil 3 (37.5%). ESBL-EC isolates were highly resistant to ampicillin (100%), cefuroxime (100%), ciprofloxacin (53.6%), and tetracycline (58.2%). However, all ESBL-EC were susceptible to meropenem. Commonly detected AMR genes were blaTEM-1B (32%), tetA (48%) and sul2 (32%), with majority recovered from healthy human and soil samples. The dominant sequence types found were 12% (3) for ST10, ST 9312, ST 206, and ST 4151. The prevalent plasmid replicon types detected were IncFIB (Apoo1918) (40%) and IncFII (pCoo) (36%).
conclusionWithin the metropolis surveyed, we identified MDR ESBL-EC harbouring various AMR genes and plasmid replicon types with diverse E. coli sequence types in healthy humans, animals, and the environment. The detection of blaCTX-M-15 in agricultural soil isolate is worrisome, emphasizing the need for a "One Health" approach in combating AMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.